HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lipid profiles of patients with manifest coronary versus peripheral atherosclerosis - Is there a difference?

AbstractAIM:
Peripheral arterial disease (PAD) and coronary artery disease (CAD) are both caused by atherosclerosis. Serum lipids and lipoproteins are predictive of the development of atherosclerosis but it is not clear if they differ in the two manifestations, PAD and CAD. We tested whether a more detailed characterization of the lipid and lipoprotein patterns of PAD and CAD allows a clear differentiation between the two atherosclerotic phenotypes.
METHODS:
A cohort of 274 statin-naïve patients with either newly diagnosed imaging proven PAD (n = 89) or stable CAD (n = 185) was characterized using nuclear magnetic resonance- and liquid chromatography-tandem mass spectrometry-based advanced lipid and lipoprotein analysis. An independent cohort of 1239 patients with PAD and CAD was used for validation.
RESULTS:
We found a significant difference in markers of inflammation as well as ceramide and phosphatidylcholine levels between patients with PAD and CAD. In contrast, basic lipid markers including total cholesterol, LDL cholesterol, HDL cholesterol, lipoprotein(a) or detailed lipoprotein profiles did not differ significantly between patients with PAD and CAD. Applying ratios and scores derived from ceramides and phosphatidylcholines further improved the discrimination between PAD and CAD. These significant differences were independent of body composition, from the status of smoking or type 2 diabetes mellitus, and also from apolipoprotein C-III and other inflammatory parameters which were different between CAD and PAD.
CONCLUSION:
The present study clearly suggests that PAD and CAD differ in terms of their ceramide- and phosphatidylcholine-based lipid patterns but not in lipoprotein characteristics.
AuthorsAndreas Leiherer, Axel Mündlein, Eva Maria Brandtner, Christoph H Säly, Hana Ramadani, Alexander Vonbank, Arthur Mader, Jörn F Dopheide, Antti Jylhä, Mitja Lääperi, Reijo Laaksonen, Winfried März, Peter Fraunberger, Marcus Kleber, Heinz Drexel
JournalJournal of internal medicine (J Intern Med) Vol. 290 Issue 6 Pg. 1249-1263 (12 2021) ISSN: 1365-2796 [Electronic] England
PMID34337800 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021 The Association for the Publication of the Journal of Internal Medicine.
Chemical References
  • Ceramides
  • Lipids
  • Lipoproteins
  • Phosphatidylcholines
Topics
  • Atherosclerosis (blood)
  • Ceramides (blood)
  • Coronary Artery Disease (blood)
  • Diabetes Mellitus, Type 2
  • Humans
  • Lipids (blood)
  • Lipoproteins (blood)
  • Peripheral Arterial Disease (blood)
  • Phosphatidylcholines (blood)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: